Synthetic modification of salinomycin: selective O-acylation and biological evaluation
Author
Summary, in English
Salinomycin has found renewed interest as an agent for prevention of cancer recurrence through selectively targeting cancer stem cells. Strategies for generation of improved salinomycin analogs by individual modification of its hydroxyl groups are presented. An evaluation of the dose-response effects of the resulting library on breast cancer cell lines shows that acylation of the C20 hydroxyl can be used to improve IC50 values down to one fifth that of salinomycin.
Department/s
- Centre for Analysis and Synthesis
- Functional zoology
- Breastcancer-genetics
- NanoLund: Centre for Nanoscience
- BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
Publishing year
2013
Language
English
Pages
9944-9946
Publication/Series
Chemical Communications
Volume
49
Issue
85
Document type
Journal article
Publisher
Royal Society of Chemistry
Topic
- Chemical Sciences
Status
Published
ISBN/ISSN/Other
- ISSN: 1364-548X